- Asian shares trade mixed amid a lack of major catalysts, same old news.
- Vaccine optimism prevails, US stimulus talks derail off-late but not closed yet.
- RBI stands pat, Japan releases draft stimulus details.
- US-China tussle intensifies, Aussie Retail Sales eased, South Korean Current Account Balance grew in October.
Having refreshed the record high earlier in the day, MSCI’s index of Asia-Pacific shares outside Japan gains 0.90% while Japan’s Nikkei 225 drops nearly 0.20% ahead of Friday’s European session.
The risk barometers initially cheered increasing odds of the US stimulus and the nearness to the coronavirus (COVID-19) vaccine. However, US Senate Majority Leader Mitch McConnell’s rejection of the $908 billion stimulus proposal, as well as the fresh Sino-American tussle, weighed on risks afterward.
Not only the Trump administration’s confirmation of four Chinese companies to get blacklisted due to the military ties, but the visa limit for the Chinese Communist Party members and their families also teased China Daily to warn the US. However, CNN came out with a different tone suggesting US President-elect Joe Biden has a constructive outlook than Donald Trump despite not liking Beijing.
Elsewhere, the RBI revised up the fiscal year 2021 GDP forecast while keeping the benchmark rates unchanged whereas Japan released a draft stimulus suggesting a hike in helps to private firms. Details suggested further push to the Go to travel and eat-out campaigns until the end of June 2021 as well as measures to adopt a powerful economic package and to avoid a return to deflation, per Reuters.
On the data front, Australia’s second reading of October’s Retail Sales eased from 1.6% initial forecasts to 1.4% whereas South Korea’s Current Account Balance rose from 8.49B expected to 11.66B.
That said, shares in Australia and China stay mildly bid whereas those from India and South Korea pick-up bids with nearly 1.0% gains by press time. Stock futures are also up, near 0.25%, after Wall Street benchmarks refreshed record tops before closing with mixed results.
Moving on, market players will keep their eyes on the vaccine and stimulus headlines whereas the US employment report for November will also be the key to watch next.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
GBP/USD tests seven-month lows below 1.2500
GBP/USD continues to lose ground for the third consecutive day, trading around 1.2490 during the Asian hours on Friday. The daily chart analysis suggests an ongoing bearish bias as the pair is confined within the descending channel pattern.
EUR/USD struggles near 1.3060 area, just above two-year low ahead of US PCE data
The EUR/USD pair continues with its struggle to attract any meaningful buyers and oscillates in a range around the 1.0360 area during the Asian session on Friday. Spot prices remain close to a near-one-month low touched on Thursday and seem poised to register its lowest weekly close since November 2022.
Gold price holds steady around $2,600; upside potential seems limited
Gold price attracts some haven flows amid the looming risk of a US government shutdown. The global flight to safety-led pullback in the US bond yields further benefits the XAU/USD. The Fed’s hawkish stance acts as a tailwind for the USD and should cap any further upside.
Bitcoin, Ethereum and Ripple crash, wiping $1.17 billion from the market
Bitcoin price trades below $98,000 on Friday after declining more than 6% this week. Ethereum and Ripple followed BTC’s footsteps, closing below their key support and declining 12% and 4.5%, respectively, this week.
Bank of England stays on hold, but a dovish front is building
Bank of England rates were maintained at 4.75% today, in line with expectations. However, the 6-3 vote split sent a moderately dovish signal to markets, prompting some dovish repricing and a weaker pound. We remain more dovish than market pricing for 2025.
Best Forex Brokers with Low Spreads
VERIFIED Low spreads are crucial for reducing trading costs. Explore top Forex brokers offering competitive spreads and high leverage. Compare options for EUR/USD, GBP/USD, USD/JPY, and Gold.